MedTrace Logo

Aqueous Suppressant Versus Aqueous Outflow on Ocular Blood Flow

NCT01308788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2014-01-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study will be to compare the aqueous production suppressant to aqueous outflow drugs in terms of the response to known vascular parameters. Specifically; systemic perfusion pressure, retrobulbar blood flow and retinal microcirculation.

Conditions

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Alon Harris, PhD · Indiana University School of Medicine

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01308788 on ClinicalTrials.gov